RGEN Q4 2020 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q4 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$109M+56.4% YoY

Gross Profit

$56M51.7% margin

Operating Income

$22M20.6% margin

Net Income

$20M18.1% margin

EPS (Diluted)

$0.36

QoQ Revenue Growth

+15.5%

Cash Flow

Operating Cash Flow

$15M

Free Cash Flow

$3M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$1.9B

Total Liabilities

$374M

Stockholders' Equity

$1.5B

Cash & Equivalents

$717M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$109M	$69M	+56.4%
Gross Profit	$56M	$36M	+57.8%
Operating Income	$22M	$6M	+279.2%
Net Income	$20M	$4M	+446.6%

Revenue Segments

Product

$109M100%

Royalty

$33,0000%